Picture of PCI Biotech Holding ASA logo

PCIBo — PCI Biotech Holding ASA News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Norwegian Stocks: Shares lower despite higher oil prices, Kongsberg Gr jumps after Q2 earning

OSLO, Aug 24 (Reuters) - 
 * Norwegian shares traded down on Friday 
 * Oslo's benchmark index  .OSEBX  fell 0.23 pct, or 2.05
points, to 904.32 points and was up by 11.29 pct year-to-date
 * The broader Oslo All Share Index  .OSEAX  was down 0.15
percent 
 * Brent crude futures  LCOc1 , a trigger for the oil heavy Oslo
Bourse, rose $0.54 to $75.27 a barrel  O/R 
 * Among the biggest firms on the Oslo Bourse, Equinor  EQNR.OL 
fell 0.74 pct, Telenor  TEL.OL  fell 0.06 pct and DNB  DNB.OL 
rose 0.41 pct
 * Turnover at the Oslo Bourse was 1.3 billion Norwegian crowns
and most traded shares were Equinor EQNR.OL , Telenor TEL.OL 
and Salmar SALM.OL 
 * Shares of Kongsberg Gruppen ASA  KOG.OL  were up 11.45 pct to
NOK 167.4
    
 * Kongsberg Gruppen: Keeps view of flat revenues in 2018,
margins and orders are rising  urn:newsml:reuters.com:*:nL8N1VF1OU
  * Shares of Marine Harvest ASA MHG.OL  were down 0.87 pct to
NOK 176.55
 
 * Most salmon share under pressure after disappointing Q2
reports earlier this weak despite optimistic outlook
 
 * Biggest gainers: Gaming Innovation Group Inc 8.68 pct and
B2holding ASA 2.19 pct
 * Biggest losers: PCI Biotech Holding ASA  PCIB.OL  -24.11 pct,
Nordic Nanovector ASA  NANOV.OL  -3.71 pct and Borr Drilling Ltd
 BDRILL.OL  -2.75 pct
 * PCI Biotech proposed a fully underwritten rights issue of NOK
360 mln at a price of NOK 30.00 per share  urn:newsml:reuters.com:*:nFWN1VF068
 
 * Abroad European shares  .FTEU3  rose 0.13 pct, Japan's main
share index Nikkei  .N225  ended up 0.85 pct, while in China
Shanghai index  .SSEC  was up 0.18 pct and Dow Jones index
 .DJI  in the United States -0.30 pct on Thursday

 (Reporting By Ole Petter Skonnord)
 ((olepetter.skonnord@thomsonreuters.com; 0047 23 31 65 97;))

Recent news on PCI Biotech Holding ASA

See all news